Literature DB >> 6128611

Incidence of second malignant neoplasms in children: results of an international study.

V Miké, A T Meadows, G J D'Angio.   

Abstract

The incidence of second malignant neoplasms (SMNs) in children was estimated from data provided by ten paediatric oncology centres. During 1950-70 nearly 15 000 new patients were seen at these institutions. With follow-up through 1979, 113 eligible cases of SMN were reported. To estimate the number of person-years at risk, a common set of survival distributions, specific for tumour type and calendar period, was applied to the patient entry data at each institution. The annual incidence of SMNs 5-15 years after diagnosis of first tumour was found to be 188/100 000; this represents an approximate ten-fold increase over the age-adjusted expected rate of cancer in the general population. The corresponding incidence during the first 5 years was 85/100 000/year, a seven-fold increase in risk. The estimated cumulative probability of SMN reached 3.3% at 20 years.

Entities:  

Mesh:

Year:  1982        PMID: 6128611     DOI: 10.1016/s0140-6736(82)91524-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Wei Liu; Wendy Leisenring; Yutaka Yasui; Sue Hammond; Smita Bhatia; Joseph P Neglia; Marilyn Stovall; Deokumar Srivastava; Leslie L Robison
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

Review 2.  Late effects of total body irradiation.

Authors:  A D Leiper
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

3.  Second primary tumours.

Authors:  J E Kingston
Journal:  Arch Dis Child       Date:  1985-08       Impact factor: 3.791

4.  Medulloblastoma in a patient successfully treated for immature teratoma of the ovary.

Authors:  S Yalçin; N Güler; F Söylemezoğlu
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

5.  Embryonal rhabdomyosarcoma of the prostate.

Authors:  Kazuhiro Niimi; Yoshihiro Hashimoto; Satoshi Kurokawa; Atsushi Okada; Keiichi Tozawa; Kenjiro Kohri
Journal:  Int J Clin Oncol       Date:  2010-01-20       Impact factor: 3.402

6.  A male patient with malignant lymphoma and thyroid papillary carcinoma after pediatric renal transplantation.

Authors:  Osamu Motoyama; Jiro Takasu; Takeshi Kawamura; Atushi Aikawa; Yukari Shigetomi; Chiharu Nara; Akira Ohara; Kikuo Iitaka; Akira Hasegawa
Journal:  Clin Exp Nephrol       Date:  2009-07-15       Impact factor: 2.801

Review 7.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

8.  Ewing's Sarcoma and Second Malignancies.

Authors:  Joshua D Schiffman; Jennifer Wright
Journal:  Sarcoma       Date:  2010-10-13

9.  Simultaneous occurrence of osteosarcoma and osteochondroma following treatment of neuroblastoma with chemotherapy, radiotherapy, and bone marrow transplantation.

Authors:  M Poustchi-Amin; J C Leonidas; S S Elkowitz
Journal:  Pediatr Radiol       Date:  1996

10.  Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.

Authors:  J H Olsen; S Garwicz; H Hertz; G Jonmundsson; F Langmark; M Lanning; S O Lie; P J Moe; T Møller; R Sankila
Journal:  BMJ       Date:  1993-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.